Regulatory initiatives for standardized organoid modeling emphasize the need for robust methodologies that minimize the impact of the human factor on cell health. While the landscape of modern cell biology has been transformed by sophisticated genetic engineering tools, the fundamental day-to-day
Singapore’s integration into European testing networks ensures that biological drugs manufactured in the city-state meet the world's most stringent laboratory standards. This development signifies a broader shift in the city-state's role, transitioning from a localized regulatory body into a
The upcoming appellate verdict for Kang will address specific charges of submitting fraudulent animal testing data to the Ministry of Food and Drug Safety for a potential antiviral drug. This legal proceeding serves as a critical juncture for the South Korean pharmaceutical industry, highlighting
Pharma developers must reconcile their mathematical models with biological reality to ensure that effective treatments for systemic lupus are not sidelined by outdated trial designs. The recent clinical development of enpatoran, a highly anticipated first-in-class treatment for systemic lupus
While the COVID-19 pandemic accelerated the shift toward virtual care, the rapid growth of telehealth platforms has outpaced the federal regulations intended to protect sensitive patient data. For millions of Americans, the appeal of services like Hims & Hers, BetterHelp, and GoodRx lies in the
Market analysts predict that the rising cost of compliance will lead to a consolidation of healthcare vendors, leaving only those who can pass rigorous security audits. This projection follows the recent finalization of a massive $2.3 million multistate settlement involving the Wisconsin Department
